MaxCyte, Inc

Contributing Author

Recent Articles by MaxCyte, Inc

Oct-08	MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025 MXCT GlobeNewswire
Oct-06	MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors MXCT GlobeNewswire
Sep-22	MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability MXCT GlobeNewswire
Aug-06	MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance MXCT GlobeNewswire
Aug-04	MaxCyte Signs Platform License Agreement with Adicet Bio MXCT GlobeNewswire
Jul-31	MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline MXCT GlobeNewswire
Jul-09	MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 MXCT GlobeNewswire
Jun-11	MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies MXCT GlobeNewswire
May-07	MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance MXCT GlobeNewswire
May-07	MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance MXCT GlobeNewswire